Although SRL172 immunization was associated with reduced laboratory-confirmed tuberculosis among adults with HIV infection [11], and SRL172 elicited IFN-γ responses to mycobacterial antigens [10], IFN-γ responses to mycobacterial antigens did not correlate with vaccine-mediated protection from tuberculosis. The gene discussed is IFNG; the disease is tuberculosis.